Concepedia

Carmen Barnes

CB

10

Publications

1.8K

Citations

10

H-Index

1995

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Massachusetts Institute of Technology

Harvard University

Harvard–MIT Division of Health Sciences and Technology

Skolkovo Institute of Science and Technology

Carmen Barnes is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, vascular biology, and gene expression.

Top concepts

Publications per year

1995–2018

10

Publications

10

In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight

James E. Dahlman, Carmen Barnes, Omar F. Khan et al. · Nature Nanotechnology · 2014 · 567 citations · Full text

, , +7

Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates

Yizhou Dong, Kevin T. Love, J. Robert Dorkin et al. · Proceedings of the National Academy of Sciences · 2014 · 470 citations · Full text

FGF Regulates TGF-β Signaling and Endothelial-to-Mesenchymal Transition via Control of let-7 miRNA Expression

Pei‐Yu Chen, Lingfeng Qin, Carmen Barnes et al. · Cell Reports · 2012 · 294 citations · Full text

Microbial iron transport via a siderophore shuttle: A membrane ion transport paradigm

Alain Stintzi, Carmen Barnes, Jide Xu et al. · Proceedings of the National Academy of Sciences · 2000 · 254 citations · Full text

Transforming Growth Factor-β Promotes Inactivation of Extracellular Thyroid Hormones via Transcriptional Stimulation of Type 3 Iodothyronine Deiodinase

Stephen A. Huang, Michelle A. Mulcahey, Alessandra Crescenzi et al. · Molecular Endocrinology · 2005 · 71 citations · Full text

, , +19

Rows per page

1–5 of 10